glaxosmithkline plc (GSK:London)

Executive Profile*

Background*

Sir Andrew Philip Witty has been the Chief Executive Officer of GlaxoSmithKline Group of GlaxoSmithKline Pakistan Ltd since May 2008. Sir Witty has been the Chief Executive Officer at GlaxoSmithKline plc (GSK Plc) at GlaxoSmithKline Bangladesh Ltd. and GlaxoSmithKline Biologicals S.A since May 21, 2008 and also serves as a Member of its Corporate Executive Team. He served as Chief Executive Officer at GlaxoSmithKline Consumer Nigeria plc. Sir Witty served as the President ... of Pharmaceuticals Europe at GlaxoSmithKline PLC since January 2003 and also served as its Chief Executive Officer Designate since October 2007. He served as a Senior Vice President of Asia Pacific of Pharmaceuticals International since January 2001 and was responsible for its operations in Asia Pacific, based in Singapore. He joined Glaxo UK in 1985. He held various positions in the UK, including Director of Pharmacy & Distribution in Glaxo Pharmaceuticals UK, Director of Business Development of Biocompatibles Limited and International Product Manager of Glaxo Holdings PLC. He served as Managing Director of Glaxo South Africa and Area Director of South and East Africa. He served as a Vice President and General Manager of Marketing of Glaxo Wellcome Inc., a subsidiary of GlaxoSmithKline with responsibility for strategy development, marketing execution and new product positioning. Sir Witty served as an Economic Adviser to the Governor of Guangzhou, China from 2000 to 2002. He has been Director of GlaxoSmithKline Group since January 2008. He has been an Executive Director at GlaxoSmithKline plc since January 31, 2008. He has been the Lead Non-Executive Board Member at U.K. Department for Business, Innovation & Skills since January 1, 2011. He served as a Director of Singapore Economic Development Board. He serves on the Imperial College Commercialisation Advisory Board. He is a Member of the INSEAD UK Council, Health Innovation Council in the UK and a Director of the Office for Strategic Coordination of Health Research. He served as a Board Member of the Singapore Land Authority Board under the Ministry of Law from 2002 to 2003. Sir Witty holds BA in Economics from Nottingham University in the UK.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
GSK:LN	1,749.50 GBp	+7.50

COMPETITOR COMPENSATION